Novartis AG-RegNVSEF
13F holders, Q4 2025 (December 31)2holders −2
0new positions
2sold out
$138.12avg. 13F price*
At the end of Q4 2025, 2 institutions reported holding Novartis AG-Reg (NVSEF) in their 13F filings, down 2 from Q3 2025. 0 opened new positions and 2 sold out. The largest holders were Partners Capital Investment Group, LLP ($4.3M) and Generali Investments CEE, investicni spolecnost, a.s. ($2.5M).
- Company
- Novartis AG-Reg
- CUSIP
- H5820Q150
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $16.3M |
All 13F filers, Q3 2025 → Q4 2025: 140,710 shares sold, net −140,710 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Partners Capital Investment Group, LLP | 0.16% | Reduce -26.2% | 31,324 | $4.3M |
| Generali Investments CEE, investicni spolecnost, a.s. | 0.18% | No change | 18,053 | $2.5M |
"% of holder's portfolio" is NVSEF's weight in each manager's 13F, not the share of Novartis AG-Reg the manager owns.